PA8505801A1 - Derivados de higromicina - Google Patents

Derivados de higromicina

Info

Publication number
PA8505801A1
PA8505801A1 PA20008505801A PA8505801A PA8505801A1 PA 8505801 A1 PA8505801 A1 PA 8505801A1 PA 20008505801 A PA20008505801 A PA 20008505801A PA 8505801 A PA8505801 A PA 8505801A PA 8505801 A1 PA8505801 A1 PA 8505801A1
Authority
PA
Panama
Prior art keywords
compounds
invention refers
hygromycin
derivatives
hygromycin derivatives
Prior art date
Application number
PA20008505801A
Other languages
English (en)
Inventor
Katherine Elizabeth Brighty
Ii Robert Gerald Linde
Matthew Merrill Hyaward
Takushi Kaneko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8505801A1 publication Critical patent/PA8505801A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA 1 Y A SALES, PROMEDICAMENTOS Y SOLVATOS FARMACEUTICAMENTE ACEPTABLES DE ESTOS, EN LOS QUE X, Y, V, W¹, W², Z¹ Y Z² SON COMO SE HAN DEFINIDO ANTERIORMENTE. LA INVENCION SE REFIERE TAMBIEN A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS ANTERIORES Y A PROCEDIMIENTOS DE TRATAMIENTO DE INFECCIONES BACTERIANAS Y PROTOZOOARIAS EN MAMIFEROS POR ADMINISTRACION DE LOS COMPUESTOS ANTERIORES.
PA20008505801A 1999-10-29 2000-10-26 Derivados de higromicina PA8505801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16258199P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
PA8505801A1 true PA8505801A1 (es) 2002-08-26

Family

ID=22586256

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20008505801A PA8505801A1 (es) 1999-10-29 2000-10-26 Derivados de higromicina

Country Status (32)

Country Link
US (1) US6562792B1 (es)
EP (1) EP1224197A1 (es)
JP (1) JP2003512473A (es)
KR (1) KR20020063885A (es)
CN (1) CN1382150A (es)
AP (1) AP2002002494A0 (es)
AR (1) AR023282A1 (es)
AU (1) AU7549400A (es)
BG (1) BG106727A (es)
BR (1) BR0015153A (es)
CA (1) CA2389191A1 (es)
CO (1) CO5261498A1 (es)
CZ (1) CZ20021355A3 (es)
EA (1) EA200200292A1 (es)
EE (1) EE200200228A (es)
GT (1) GT200000185A (es)
HK (1) HK1049672A1 (es)
HU (1) HUP0203525A3 (es)
IL (1) IL148577A0 (es)
IS (1) IS6311A (es)
MA (1) MA26838A1 (es)
MX (1) MXPA02004360A (es)
NO (1) NO20021850D0 (es)
OA (1) OA12081A (es)
PA (1) PA8505801A1 (es)
PE (1) PE20010763A1 (es)
PL (1) PL357083A1 (es)
SK (1) SK5472002A3 (es)
SV (1) SV2002000211A (es)
TN (1) TNSN00211A1 (es)
TR (1) TR200201145T2 (es)
WO (1) WO2001030795A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2410643A1 (en) 2000-06-02 2001-12-06 Pfizer Products Inc. Hygromycin a derivatives for the treatment of bacterial and protozoal infections
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
US7923439B2 (en) * 2008-10-15 2011-04-12 Tyco Healthcare Group Lp Hydroxamate compositions
US20210275559A1 (en) * 2018-08-20 2021-09-09 Kim Lewis Hygromycin a compounds and methods of treating spirochete diseases
AR120680A1 (es) 2019-12-06 2022-03-09 Vertex Pharma Tetrahidrofuranos sustituidos como moduladores de canales de sodio
AR126073A1 (es) 2021-06-04 2023-09-06 Vertex Pharma N-(hidroxialquil(hetero)aril)tetrahidrofuran carboxamidas como moduladores de canales de sodio

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2352332C (en) * 1998-12-02 2004-12-07 Pfizer Products Inc. Hygromycin a derivatives

Also Published As

Publication number Publication date
CA2389191A1 (en) 2001-05-03
HUP0203525A3 (en) 2003-08-28
IL148577A0 (en) 2002-09-12
AU7549400A (en) 2001-05-08
CN1382150A (zh) 2002-11-27
JP2003512473A (ja) 2003-04-02
GT200000185A (es) 2002-04-18
OA12081A (en) 2006-05-04
CO5261498A1 (es) 2003-03-31
TR200201145T2 (tr) 2002-09-23
NO20021850L (no) 2002-04-19
CZ20021355A3 (cs) 2002-11-13
AP2002002494A0 (en) 2002-06-30
NO20021850D0 (no) 2002-04-19
EE200200228A (et) 2003-06-16
IS6311A (is) 2002-03-19
TNSN00211A1 (fr) 2005-11-10
MA26838A1 (fr) 2004-12-20
WO2001030795A1 (en) 2001-05-03
BG106727A (bg) 2003-01-31
US6562792B1 (en) 2003-05-13
EA200200292A1 (ru) 2002-10-31
BR0015153A (pt) 2002-07-16
HUP0203525A2 (hu) 2003-02-28
MXPA02004360A (es) 2002-11-07
PE20010763A1 (es) 2001-07-25
PL357083A1 (en) 2004-07-12
SK5472002A3 (en) 2003-02-04
AR023282A1 (es) 2002-09-04
KR20020063885A (ko) 2002-08-05
HK1049672A1 (zh) 2003-05-23
EP1224197A1 (en) 2002-07-24
SV2002000211A (es) 2002-07-16

Similar Documents

Publication Publication Date Title
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
PA8494101A1 (es) Derivados heterociclicos utiles como agentes anticancerosos
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
PA8495101A1 (es) Derivados de 13-metileritromicina
YU30702A (sh) Novi derivati benzoimidazola, korisni agensi protiv proliferacije
SE9904508D0 (sv) New compounds
SE9904505D0 (sv) Novel compounds
GT200000005A (es) Derivados biciclicos sustituidos utiles como agentes contra el cancer.
JO2503B1 (en) Benzathiazole derivatives
MXPA03005464A (es) Agentes antivirales.
BRPI0411891A (pt) pirazol[3,4-b]piridin-6-onas como inibidores de gsk-3
DE60001586D1 (de) Diphenyl-piperidin derivate
SE0102055D0 (sv) New Compounds
CO4810376A1 (es) Derivados de eritromicina triciclicos
PA8505801A1 (es) Derivados de higromicina
PA8471801A1 (es) Derivados de higromicina a
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
SE0102058D0 (sv) New Salts II
PA8518101A1 (es) Derivados de higromicina a
ECSP003744A (es) Derivados de higromicina
UY26421A1 (es) Derivados de higromicina
DE60109496D1 (de) Streptograminderivate, deren herstellung und zusammensetzungen, die diese verbindungen enthalten
NO20014889D0 (no) Fremgangsmåte for fremstilling av medisinske midler